million
children
age
year
die
pneumonia
everi
year
wide
rang
pathogen
recognis
caus
agent
pneumonia
case
remain
aetiolog
undiagnos
despit
continu
optimis
diagnost
test
detect
respiratori
pathogen
differ
method
develop
identif
unsuspect
new
diverg
pathogen
recent
year
techniqu
led
discoveri
sever
virus
respiratori
specimen
includ
human
metapneumoviru
bocaviru
wu
ki
polyomavirus
torqu
teno
viru
ttv
confirm
subsequ
caus
agent
lower
respiratori
tract
infect
lrti
involv
virus
remain
wide
debat
issu
ttv
belong
recent
creat
viral
famili
anellovirida
compos
singlestrand
circular
dna
virus
ttv
alphatorqueviru
torqu
teno
midi
viru
gammatorqueviru
torqu
teno
mini
viru
ttmv
betatorqueviru
studi
isol
characteris
three
new
speci
ttmv
ttmvli
detect
pleural
fluid
children
hospitalis
franc
parapneumon
empyema
ppe
method
pathogen
discoveri
patholog
increas
incid
associ
high
morbid
frequent
requir
prolong
hospitalis
invas
procedur
respiratori
tract
thought
site
primari
infect
continu
replic
ttv
conduct
investig
evalu
extent
new
virus
may
associ
patholog
report
ttmvli
isol
activ
replic
alveolar
epitheli
cell
abl
modul
innat
immun
respons
prospect
studi
perform
children
age
month
year
male
femal
hospitalis
ppe
april
march
paediatr
intens
care
unit
hospic
civil
de
lyon
lyon
franc
studi
approv
particip
institut
review
board
ce
sign
inform
consent
obtain
parent
nasopharyng
aspir
obtain
use
dispos
mucu
extractor
within
h
admiss
pleural
effus
sampl
collect
time
chest
drain
insert
sampl
kept
frozen
studi
presenc
common
respiratori
pathogen
test
nasal
aspir
pleural
effus
sampl
use
ftd
respiratori
pathogen
assay
fast
track
diagnost
junglinst
luxembourg
combin
agpathid
onestep
rtpcr
kit
ambion
austin
tx
usa
total
nucleic
acid
extract
use
easymag
platform
craponn
franc
name
easymag
recommend
manufactur
five
neg
pleural
effus
sampl
subject
pathogen
discoveri
protocol
adapt
alland
et
al
base
clone
sequenc
random
rtpcr
product
homebrew
sequenc
analysi
softwar
use
identifi
new
diverg
sequenc
deposit
databas
three
five
sampl
harbour
fragment
ttmv
sequenc
subject
ttmv
fulllength
genom
amplif
invers
pcr
backtoback
primer
tabl
amplicon
clone
sequenc
strand
use
programm
http
megasoftwarenetmegaphp
multipl
align
gener
clustalw
wwwclustalorgomega
phylogenet
tree
construct
neighbourjoin
method
predict
secondari
structur
model
rna
structur
softwar
dh
mathew
zuker
dh
turner
detail
procedur
given
onlin
supplementari
materi
three
fulllength
genom
obtain
present
studi
deposit
genbank
databas
follow
access
number
two
cell
line
use
studi
replic
new
isol
ttmv
human
embryon
kidney
hek
cell
line
alveolar
epitheli
cell
line
cellulonet
bioscienc
gerlandlyon
sud
lyon
franc
cell
maintain
dmem
fetal
bovin
serum
mm
glutamin
antibiot
cell
maintain
medium
fetal
bovin
serum
mm
glutamin
antibiot
clone
ttmv
dna
linearis
ecorv
bamhi
roch
diagnost
meylan
franc
viral
vector
dna
cotransfect
cell
per
cell
plate
jetpei
reagent
polyplustransfect
illkirch
franc
recommend
manufactur
control
includ
transfect
vector
alon
cell
transfect
jetpei
alon
transfect
cultur
incub
overnight
carbon
dioxid
h
cell
wash
three
time
pb
ad
fresh
medium
transfect
effici
optimis
report
plasmid
infect
studi
healthi
cell
seed
plate
infect
supernat
ttmv
dnatransfect
cell
harvest
day
posttransfect
incub
carbon
dioxid
h
h
h
cell
wash
three
time
pb
incub
fresh
medium
h
experi
perform
least
twice
duplic
experi
supernat
collect
prescrib
time
centrifug
immedi
treat
dnasei
h
frozen
replic
ttmv
dna
extract
use
easymag
elut
cell
harvest
ml
nuclisen
lysi
buffer
extract
nucleic
acid
easymag
elut
elut
buffer
total
cellular
dna
digest
dpni
ndeii
cut
dammethyl
gatcsit
input
ttmv
nonmethyl
gatcsit
replic
ttvmv
respect
tabl
complet
digest
dna
reduc
background
level
observ
qpcr
exonucleas
iii
exoiii
fermenta
burlington
canada
ad
describ
elsewher
fulllength
genom
ttmv
detect
invers
pcr
briefli
reaction
mix
compos
nucleic
acid
primer
tabl
mm
deoxynucleotid
triphosph
mix
expand
high
fidel
enzym
mix
invitrogen
darmstadt
germani
quantif
replic
ttmv
achiev
taqman
realtim
pcr
assay
eurogentec
sera
belgium
primer
target
specif
gatcsit
qpcr
assay
optimis
previouli
recommend
amplif
step
realis
volum
contain
iq
supermix
biorad
hercul
ca
usa
primer
probe
tabl
dna
amplif
detect
detect
machin
biorad
dna
untransfect
cell
includ
reaction
transfect
studi
replic
rate
calcul
ratio
quantifi
amount
replic
ttmv
detect
dpni
digest
total
quantifi
amount
ttmv
replic
residu
input
ttmv
genom
cellfre
supernat
collect
ttmvinfect
cell
line
cultur
assay
simultan
quantif
human
epiderm
growth
factor
eotaxin
granulocyt
colonystimul
factor
gcsf
granulocytemacrophag
colonystimul
factor
gmcsf
interferon
ifn
interleukin
il
monocyt
chemoattract
protein
mcp
macrophag
inflammatori
protein
mip
tumour
necrosi
factor
tnf
vascular
endotheli
growth
factor
vegf
use
commerci
multiplex
beadbas
immunoassay
kit
milliplex
millipor
billerica
usa
identif
main
respiratori
agent
nasal
aspir
pleural
effus
sampl
children
hospitalis
sever
pneumonia
perform
use
sensit
multiplex
realtim
molecular
assay
nasal
aspir
sampl
rhinoviru
parainfluenza
virus
human
metapneumoviru
found
main
respiratori
pathogen
tabl
bacteri
agent
found
pleural
effus
sampl
wherea
remain
undiagnos
pathogen
discoveri
protocol
base
random
rtpcr
perform
five
neg
pleural
effus
sampl
sever
short
sequenc
relat
ttmv
obtain
three
characteris
ttmv
requir
amplif
sequenc
fulllength
viru
genom
betatorquevirusspecif
invers
pcr
perform
correspond
ttmvli
genom
amplifi
ttmvli
genom
compos
bp
bp
bp
respect
use
pcr
ttmvli
genom
found
pleural
effus
sampl
also
identifi
correspond
nasal
aspir
sampl
patient
among
three
patient
pleural
effus
sampl
posit
ttmv
two
male
one
femal
age
month
month
month
respect
present
clinic
featur
patient
cohort
phylogenet
analys
carri
nucleotid
sequenc
predict
open
read
frame
orf
recommend
intern
committe
taxonomi
virus
base
phylogenet
tree
fig
three
new
isol
ttmvli
belong
genogroup
relat
previous
identifi
maximum
ident
maximum
ident
isol
ttmvli
isol
possess
least
three
orf
one
major
compos
amino
acid
aa
respect
sever
overlap
orf
two
overlap
orf
aa
aa
respect
oppos
orf
aa
addit
aa
one
featur
virus
highli
conserv
region
utr
shown
figur
figur
show
possess
signific
insert
form
predict
secondari
structur
rna
sequenc
fig
structur
appear
capabl
form
stabl
loopanddim
structur
transfect
linearis
viru
genom
monitor
replic
new
ttmv
isol
cell
releas
viral
particl
supernat
quantifi
newli
synthesis
genom
specif
normalis
qpcr
assay
week
initi
observ
shown
figur
ttmvli
isol
activ
replic
cell
line
signific
differ
replic
mean
rate
three
isol
cell
observ
kinet
experi
fig
mean
rate
replic
rose
regularli
day
day
reach
replic
form
ttmvli
cell
line
replic
rate
remain
rel
constant
cell
day
cell
slightli
decreas
begin
day
releas
ttmvli
particl
show
similar
pattern
replic
rate
within
cell
peak
day
posttransfect
eightfold
increas
increas
supernat
furthermor
ensur
replic
ttmvli
detect
figur
effect
correspond
viral
particl
mere
partial
fragment
dna
purpos
complet
genom
amplif
ttmvli
cell
fig
supernat
fig
measur
observ
presenc
pcr
fragment
repres
recircularis
replic
ttmv
three
ttmvli
isol
verifi
sequenc
analys
data
shown
confirm
circular
fulllength
genom
present
cell
releas
supernat
cell
indic
presenc
viral
particl
capac
produc
replic
particl
measur
quantifi
ttmvli
genom
cell
expos
pulmonari
cell
h
h
h
neosynthetis
viru
particl
releas
day
posttransfect
supernat
transfect
cell
notic
optim
condit
ttmvli
incub
supernat
transfect
cell
h
h
respect
fig
b
also
observ
effici
ttmv
cell
entri
signific
viral
load
highest
genom
equival
moreov
quantiti
ttmvli
within
cell
systemat
greater
infect
supernat
cell
within
cell
versu
h
infect
genom
equival
suggest
viral
particl
produc
pulmonari
cell
may
infecti
result
confirm
quantif
replic
ttmvli
infect
two
cell
line
fig
infect
cell
systemat
show
highest
viral
titr
increas
infect
supernat
respect
versu
increas
cell
day
observ
made
three
ttmvli
genom
data
shown
studi
use
beadbas
immunoassay
measur
level
wide
rang
inflammatori
mediat
supernat
pulmonari
cell
infect
shown
tabl
h
postinfect
ttmvli
induc
product
sever
cytokin
chemokin
significantli
enhanc
compar
produc
uninfect
cell
observ
drive
product
larg
number
proinflammatori
rant
chemotact
antiinflammatori
cytokin
well
growth
factor
gcsf
gmcsf
two
ttmvli
genom
induc
weaker
respons
induct
rant
vegf
releas
supernat
three
ttmvli
isol
infect
cell
studi
examin
potenti
involv
new
isol
ttmv
identifi
pleural
effus
sampl
pathogenesi
sever
pneumonia
children
main
find
ttmvli
deepli
colonis
lung
alveolar
epitheli
cell
effici
replic
occur
permiss
ttmvli
isol
ttmvli
infect
modul
innat
immun
respons
pulmonari
cell
induc
product
inflammatori
mediat
ppe
result
inflamm
pleura
space
consequ
infect
bacteri
pathogen
bacteria
frequent
describ
pleural
fluid
also
confirm
studi
pleural
effus
sampl
presenc
viral
origin
remain
poorli
document
studi
first
reveal
presenc
anelloviru
parapneumon
effus
anellovirus
characteris
extrem
genet
divers
high
preval
variou
popul
wide
distribut
bodi
fluid
ubiqu
togeth
absenc
suitabl
vitro
cultur
system
hamper
progress
investig
group
virus
previou
molecular
epidemiolog
studi
unequivoc
demonstr
anellovirus
implic
pathogenesi
sever
diseas
still
lack
poorli
demonstr
found
presenc
fulllength
ttmv
genom
nasal
aspir
pleural
effus
children
hospitalis
sever
pneumonia
cohort
chines
cohort
nasal
aspir
sampl
children
suffer
lrti
data
shown
correl
observ
sever
diseas
presenc
ttmv
age
sex
patient
howev
presenc
ttmv
complet
genom
link
viral
replic
may
indic
role
pathogenesi
pneumonia
studi
report
isol
three
new
fulllength
ttmv
genom
ttmvli
children
sever
pneumonia
first
step
biolog
properti
new
isol
ttmvli
investig
first
transfect
fulllength
genom
three
ttmvli
virus
ascertain
whether
viral
replic
take
place
cell
alreadi
demonstr
subsequ
alveolar
epitheli
cell
wich
act
model
type
ii
pneumocyt
describ
first
time
ttmv
like
ttv
abl
replic
cell
line
transfect
genom
thu
lead
product
infecti
virion
observ
viral
infect
effici
alveolar
cell
kidney
cell
suggest
better
tropism
ttmvli
genom
pulmonari
cell
strengthen
role
pathogenesi
lrti
hypothesis
like
porcin
circovirus
papillomavirus
potenti
pathogen
ttmv
could
restrict
speci
group
speci
inde
studi
high
genet
ttmv
divers
observ
among
differ
patient
fulllength
genom
systemat
found
differ
sampl
taken
patient
three
genom
moreov
belong
phylogenet
branch
betatorqueviru
group
investig
conserv
genom
sequenc
three
ttmvli
genom
sequenc
determin
specif
replic
pattern
present
assum
origin
replic
agtttaca
identifi
insert
base
form
stemloop
structur
conserv
detect
previous
describ
secondari
structur
could
involv
viral
pathogen
enhanc
promot
element
despit
secondari
structur
present
gain
replic
yield
observ
compar
ttmvli
howev
effect
genet
modif
could
express
anoth
biolog
manner
respons
interact
host
cell
observ
mani
virus
second
step
investig
respons
host
cell
ttmvli
infect
measur
product
solubl
mediat
implic
inflamm
process
alveolar
type
ii
epitheli
cell
maintain
alveolar
integr
form
alveolar
barrier
produc
surfact
repair
injur
type
epithelium
moreov
integr
part
lung
innat
immun
act
intensifi
function
dendrit
cell
alveolar
macrophag
cytokin
secret
cytopath
effect
observ
cell
infect
ttmvli
induc
complex
innat
immun
respons
differ
modul
three
isol
thu
ttmvli
infect
result
product
proinflammatori
cytokin
includ
previous
describ
signific
level
antiinflammatori
cytokin
also
measur
corrobor
ttmvli
may
modifi
innat
immun
balanc
alreadi
demonstr
ttv
fact
differ
isol
ttmv
impact
differ
product
solubl
mediat
surpris
view
observ
viral
infect
may
reflect
recognit
differ
receptor
andor
interact
differ
molecular
pathway
seem
play
central
role
respons
ttmvli
infect
cytokin
enhanc
prolifer
cytotox
activ
tcell
natur
killer
cell
thought
key
factor
regul
host
defenc
mani
intracellular
pathogen
may
assum
ttmvlymedi
lung
inflamm
may
result
abund
secret
although
studi
would
need
prove
taken
togeth
result
suggest
ttmvli
isol
invad
alveolar
cell
replic
induc
innat
immun
imbal
respiratori
tract
studi
aim
understand
physiopatholog
implic
ttmv
aetiolog
agent
respiratori
diseas
necessari
requir
everi
newli
discov
pathogen
investig
would
allow
us
learn
presum
need
enlarg
rang
research
pathogen
anellovirus
case
ppe
order
improv
effici
diagnosi
treatment
patholog
